What should the big pharma brands do next?
Patient-centricity in pharma is of the moment, but in the rare disease space it has been a reality for many years
The world of healthcare is a long way off cracking how to communicate with Gen Z adolescents
The Scottish government aims to expand and advance their COVID-19 booster programme, following the six cases of the Omicron variant that were reported as of Monday 29 November. This decision is based on advice from the Joint Committee on Vaccination and Immunisation (JCVI).
30th November 2021
Following its recent approval of an injectable HIV-1 treatment from the National institute for Health and Care Excellence (NICE), GlaxoSmithKline (GSK) has high hopes in developing a cure for the virus in the future.
30th November 2021
An additional six cases of the Omicron variant have now been detected in Scotland, bringing the UK total so far to nine.
29th November 2021
Analyses provided by UK cancer charity Macmillan has provided insights into the repercussions experienced by patients waiting to receive treatment during the COVID-19 pandemic.
29th November 2021
After hosting a virtual ceremony in 2020, this year’s awards returned to the Royal Lancaster London hotel
26th November 2021
Alex Flynn was 36 when diagnosed with Parkinson’s in 2008 and has since raised around £400,000 in the last ten years
Deborah Stafford-Watson explores how new-era health brands are putting women first
Lance Hill, CEO of Within3, explores how pharma companies can address the life sciences insight gap
Dr Bjoern Schelter explores the role of technological innovation in transforming brain health ahead of World Alzheimer’s Day on 21 September
Mitsu Rana, Senior Director of Project Management, ICON plc
The world of healthcare is a long way off cracking how to communicate with Gen Z adolescents
Kathleen O’Brien reflects on the wider considerations of a digital drug development and health management ecosystem that straddles international boundaries
MAGAZINE EXCLUSIVE
What will it take to transform Beyond the Pill from optional industry extra to essential market opportunity?
Ulrike Lorch explores how investing in the progress of the clinical research workforce is crucial to delivering high quality, cutting-edge trials and achieving faster drug development that patients ultimately benefit from
Patient-centricity in pharma is of the moment, but in the rare disease space it has been a reality for many years
What should the big pharma brands do next?
Exploring The National Institute for Health and Care Excellence's (NICE) proposed update to its approach to health technology assessment (HTA)
MAGAZINE EXCLUSIVE
In the last 2 years, and accelerated by Covid, native advertising has exploded across healthcare for DTC and HCP marketing. Native ads have been adopted by all healthcare industries including pharma, device, health systems, retailers, pharmacies, payers, and the gamut of regional service providers. But there are still a handful of advertiser holdouts, and they are missing out on highly engaged audiences.
By Grace Oldham, Head of Business Development, at Axil Integrated Services
How immersive learning experiences can support and elevate patient-centricity goals in the pharma industry
Patient centricity that delivers the ‘triple win’ is a business essential for pharma
Wednesday, 28 September 2016 - 11:00 am
Across all industries, people are changing the ways they engage with products, services, and brands.
George Underwood
FREE - Listen again now - | VIEW NOW
Wednesday, 21 July 2021 - 2:00 pm
In healthcare, the patient voice is arguably the most important. Services and care work best when a person’s needs are fully met and they feel heard, respected and valued.
Mark Doyle, co-founder of The Method and creator of A Life in a Day
FREE | ATTEND
